| Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion (NCT01030952) | Novartis Pharmaceuticals | 2009-12-01 |
| An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment (NCT00980018) | Novartis Pharmaceuticals | 2009-12-01 |
| Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment. (NCT01022996) | Novartis Pharmaceuticals | 2009-12-01 |
| This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure (NCT01035255) | Novartis Pharmaceuticals | 2009-12-01 |
| Lapatinib in Combination With Vinorelbine (NCT01013740) | Novartis Pharmaceuticals | 2009-11-25 |
| A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma. (NCT01206764) | Novartis Pharmaceuticals | 2009-11-11 |
| Effect of Indacaterol on Inspiratory Capacity (IC) (NCT01012765) | Novartis Pharmaceuticals | 2009-11-01 |
| Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients (NCT01213641) | Novartis Pharmaceuticals | 2009-11-01 |
| SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance (NCT01266148) | Novartis Pharmaceuticals | 2009-11-01 |
| Safety and Efficacy of DNK333 in Atopic Dermatitis Patients (NCT01033097) | Novartis Pharmaceuticals | 2009-11-01 |
| A Study to Determine the Capacity of VAK694 When Combined With Allergen Immunotherapy to Bring About Specific Immune Tolerance (NCT01018693) | Novartis Pharmaceuticals | 2009-11-01 |
| LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction (NCT00887588) | Novartis Pharmaceuticals | 2009-11-01 |
| A Trial Evaluating the Effects of Zoledronic Acid 5 mg Infusion on Bone Mineral Density (BMD) in Postmenopausal Osteoporosis (PMO) Patients Between the Ages of 50 and 65 Years (NCT00909961) | Novartis Pharmaceuticals | 2009-11-01 |
| Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis (NCT01022970) | Novartis Pharmaceuticals | 2009-11-01 |
| LBH589 Alone or in Combination With Erythropoietin Stimulating Agents (ESA) in Patients With Low or Int-1 Risk Myelodysplastic Syndromes (MDS) (NCT01034657) | Novartis Pharmaceuticals | 2009-11-01 |
| Pharmacokinetics of Everolimus in Subjects With Hepatic Insufficiency (NCT00968591) | Novartis Pharmaceuticals | 2009-11-01 |
| Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema (NCT00901186) | Novartis Pharmaceuticals | 2009-11-01 |
| Efficacy, Safety and Tolerability of AFQ056 in Patients With Huntington's Disease in Reducing Chorea (NCT01019473) | Novartis Pharmaceuticals | 2009-11-01 |
| An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease (NCT01009281) | Novartis Pharmaceuticals | 2009-10-30 |
| A Study of BKM120 in Adult Japanese Patients With Advanced Solid Tumors (NCT01283503) | Novartis Pharmaceuticals | 2009-10-01 |
| Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase (NCT00991146) | Novartis Pharmaceuticals | 2009-10-01 |
| Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Maleate Via Concept1 or Simoon Devices (NCT01012739) | Novartis Pharmaceuticals | 2009-10-01 |
| Phase III Study in Refractory Behcet's Disease (NCT00995709) | Novartis Pharmaceuticals | 2009-10-01 |
| Comparison of the Effects of Indacaterol and Tiotropium on Inspiratory Capacity (NCT00999908) | Novartis Pharmaceuticals | 2009-10-01 |
| Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer (NCT01007942) | Novartis Pharmaceuticals | 2009-10-01 |
| Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma (NCT00903175) | Novartis Pharmaceuticals | 2009-10-01 |
| Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer (NCT00876395) | Novartis Pharmaceuticals | 2009-09-10 |
| Safety and Efficacy of BFH772 in Psoriasis Patients (NCT00987870) | Novartis Pharmaceuticals | 2009-09-01 |
| Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients (NCT01079143) | Novartis Pharmaceuticals | 2009-09-01 |
| Everolimus in de Novo Heart Transplant Recipients (NCT01017029) | Novartis Pharmaceuticals | 2009-09-01 |
| A Phase Ib, Open-label, Multi-center Dose-finding Study of Oral Panobinostat (LBH589) in Combination With Ara-C and Mitoxantrone as Salvage Therapy for Refractory or Relapsed Acute Myeloid Leukemia (NCT01055483) | Novartis Pharmaceuticals | 2009-09-01 |
| Imatinib (QTI571) in Pulmonary Arterial Hypertension (NCT00902174) | Novartis Pharmaceuticals | 2009-09-01 |
| Effect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled Asthma (NCT01007149) | Novartis Pharmaceuticals | 2009-09-01 |
| Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patients (NCT00983060) | Novartis Pharmaceuticals | 2009-09-01 |
| Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C (NCT00938860) | Novartis Pharmaceuticals | 2009-09-01 |
| Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures (NCT00975715) | Novartis Pharmaceuticals | 2009-09-01 |
| A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia (NCT00866281) | Novartis Pharmaceuticals | 2009-09-01 |
| Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin (NCT00958841) | Novartis Pharmaceuticals | 2009-09-01 |
| An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever. (NCT00891046) | Novartis Pharmaceuticals | 2009-09-01 |
| A Study to Evaluate Safety and Efficacy of Panobinostat in Participants With Primary Myelofibrosis (NCT00931762) | Novartis Pharmaceuticals | 2009-08-31 |
| Open Label Extension to Bridging Study CTBM100C2303 (NCT00982930) | Novartis Pharmaceuticals | 2009-08-12 |
| Efficacy and Safety of Panobinostat (LBH589) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML) (NCT00880269) | Novartis Pharmaceuticals | 2009-08-01 |
| Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1) (NCT00789828) | Novartis Pharmaceuticals | 2009-08-01 |
| Safety and Pharmacokinetics of ASA404 When Given Together With Fluvoxamine, a Selective Serotonin Receptor Reuptake Inhibitor and CYP1A2 Inhibitor (NCT01299415) | Novartis Pharmaceuticals | 2009-08-01 |
| Efficacy, Tolerability, and Comfort of 0.3% Hypromellose Eyedrops in Patients Undergoing LASIK Surgery (NCT00909324) | Novartis Pharmaceuticals | 2009-08-01 |
| Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy (NCT00790036) | Novartis Pharmaceuticals | 2009-07-24 |
| Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST) (NCT00867113) | Novartis Pharmaceuticals | 2009-07-22 |
| AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis (NCT00941031) | Novartis Pharmaceuticals | 2009-07-01 |
| Valsartan Intensified Primary Care Reduction of Blood Pressure Study (NCT00902304) | Novartis Pharmaceuticals | 2009-07-01 |
| Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection Subjects (NCT00964665) | Novartis Pharmaceuticals | 2009-07-01 |
| RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe (NCT00688753) | Novartis Pharmaceuticals | 2009-07-01 |
| Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program (NCT00956293) | Novartis Pharmaceuticals | 2009-07-01 |
| Controlled Myelofibrosis Study With Oral Janus-associated Kinase (JAK) Inhibitor Treatment-II: The COMFORT-II Trial (NCT00934544) | Novartis Pharmaceuticals | 2009-07-01 |
| Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX) (NCT00928512) | Novartis Pharmaceuticals | 2009-07-01 |
| Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA) (NCT00889863) | Novartis Pharmaceuticals | 2009-07-01 |
| Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma (NCT00941798) | Novartis Pharmaceuticals | 2009-07-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QAX576 in Asthma Patients (NCT00940160) | Novartis Pharmaceuticals | 2009-07-01 |
| Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory Factors (NCT00928889) | Novartis Pharmaceuticals | 2009-07-01 |
| Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients (NCT00939588) | Novartis Pharmaceuticals | 2009-07-01 |
| Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer (NCT00958971) | Novartis Pharmaceuticals | 2009-07-01 |
| Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA) (NCT00886769) | Novartis Pharmaceuticals | 2009-07-01 |
| Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC) (NCT00879333) | Novartis Pharmaceuticals | 2009-07-01 |
| A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients (NCT00961896) | Novartis Pharmaceuticals | 2009-07-01 |
| CAEB071 Thorough QTc Study in Healthy Volunteers (NCT01594255) | Novartis Pharmaceuticals | 2009-07-01 |
| RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe (NCT00688623) | Novartis Pharmaceuticals | 2009-06-24 |
| Long Term Study of Canakinumab (ACZ885) in Patients With Gout (NCT00927810) | Novartis Pharmaceuticals | 2009-06-05 |
| Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole (NCT00863655) | Novartis Pharmaceuticals | 2009-06-03 |
| Effect of Light Meal on Pharmacokinetic and Pharmacodynamics of Aliskiren in Patients With Mild to Moderate Hypertension (NCT00933920) | Novartis Pharmaceuticals | 2009-06-01 |
| Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With Asthma (NCT00927901) | Novartis Pharmaceuticals | 2009-06-01 |
| A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo (NCT00918957) | Novartis Pharmaceuticals | 2009-06-01 |
| A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD) (NCT00900731) | Novartis Pharmaceuticals | 2009-06-01 |
| Efficacy 2 Part Study of Identification of Keloid Biomarkers and Effect of QAX576 on Keloid Recurrence (NCT00987545) | Novartis Pharmaceuticals | 2009-06-01 |
| Epidemiological Study in Children and Adolescents With Chronic Hepatitis B (NCT01163240) | Novartis Pharmaceuticals | 2009-06-01 |
| Nilotinib Versus Standard Imatinib (400/600 mg Every Day (QD)) Comparing the Kinetics of Complete Molecular Response for Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Pts With Evidence of Persistent Leukemia by Real-time Quantitative Polymerase Chain Reaction (RQ-PCR) (NCT00760877) | Novartis Pharmaceuticals | 2009-06-01 |
| Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg (NCT00751036) | Novartis Pharmaceuticals | 2009-06-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of APL180 (NCT00907998) | Novartis Pharmaceuticals | 2009-06-01 |
| Safety, Tolerability and Pharmacokinetics of Multiple Doses of VAK694 in Atopic Subjects With Seasonal Rhinitis (NCT00929968) | Novartis Pharmaceuticals | 2009-06-01 |
| Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT00866697) | Novartis Pharmaceuticals | 2009-05-26 |
| Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure (NCT00894387) | Novartis Pharmaceuticals | 2009-05-01 |
| A Study of HSP990 Administered by Mouth in Adult Patients With Advanced Solid Tumors (NCT00879905) | Novartis Pharmaceuticals | 2009-05-01 |
| Safety/Tolerability, Pharmacokinetics/Pharmacodynamics (PK/PD) of LCZ696 in Patients With Stable Heart Failure (NCT00913653) | Novartis Pharmaceuticals | 2009-05-01 |
| Randomized Phase Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib (NCT00802841) | Novartis Pharmaceuticals | 2009-05-01 |
| Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure (NCT00894868) | Novartis Pharmaceuticals | 2009-05-01 |
| Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart Failure (NCT00923156) | Novartis Pharmaceuticals | 2009-05-01 |
| Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food (NCT00845871) | Novartis Pharmaceuticals | 2009-05-01 |
| Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer (NCT00820222) | Novartis Pharmaceuticals | 2009-04-14 |
| Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease (NCT00877383) | Novartis Pharmaceuticals | 2009-04-01 |
| A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM) (NCT00901979) | Novartis Pharmaceuticals | 2009-04-01 |
| Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) (NCT00790400) | Novartis Pharmaceuticals | 2009-04-01 |
| Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks (NCT00862706) | Novartis Pharmaceuticals | 2009-04-01 |
| Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment (NCT00881205) | Novartis Pharmaceuticals | 2009-04-01 |
| A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis (NCT00885196) | Novartis Pharmaceuticals | 2009-04-01 |
| Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis (NCT00879658) | Novartis Pharmaceuticals | 2009-03-30 |
| Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis (NCT00878072) | Novartis Pharmaceuticals | 2009-03-25 |
| Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia (NCT00824265) | Novartis Pharmaceuticals | 2009-03-12 |
| Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis (NCT00809159) | Novartis Pharmaceuticals | 2009-03-01 |
| Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease (NCT00846586) | Novartis Pharmaceuticals | 2009-03-01 |
| Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00876694) | Novartis Pharmaceuticals | 2009-03-01 |
| A Study of Nilotinib Versus Imatinib in GIST Patients (NCT00785785) | Novartis Pharmaceuticals | 2009-03-01 |
| Multiple Dose Pharmacokinetics of LCZ696 and Its Metabolites in Subjects With Severe Renal Impairment vs. Matched Healthy Subjects With Normal Renal Function (NCT01569828) | Novartis Pharmaceuticals | 2009-03-01 |